Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Heli Nevanlinna

doi:10.1016/j.gim.2025.101521

Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure

Heli Nevanlinna · 2025-07-07

Links

DOI PubMed

Journal

Genetics in Medicine

TL;DR

A novel FANCM cancer syndrome that is separate from FA and other characterized cancer susceptibility syndromes is suggested, suggesting a risk effect wider than previously described.

AI-generated by Semantic Scholar

Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure

Links

Journal

TL;DR

Institutions

Authors

Funding